Sonova (OTCMKTS:SONVY) Stock Price Passes Above 50-Day Moving Average - Here's Why

Key Points

• Sonova briefly crossed above its 50‑day moving average (50‑day MA = $46.75), reaching $47.08 intraday before last trading at $46.09 on a volume of 52,866 shares and finishing down about 1.8%.
• Analyst sentiment is mixed: BNP Paribas Exane upgraded to Strong Buy, Jefferies downgraded to Moderate Sell, Zacks moved to Hold, and the consensus from MarketBeat is a Moderate Buy (2 Strong Buy, 1 Buy, 4 Hold, 1 Sell).
• Sonova is a Switzerland‑based hearing‑care provider (brands include Phonak, Unitron and Advanced Bionics) with a 200‑day MA of $50.55 and liquidity/leverage metrics of quick ratio 0.91, current ratio 1.24 and debt/equity 0.51.

Sonova Holding (OTCMKTS:SONVY - Get Free Report)'s stock price crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $46.75 and traded as high as $47.08. Sonova shares last traded at $46.09, with a volume of 52,866 shares changing hands.

Analysts Set New Price Targets

SONVY has been the subject of several recent analyst reports. BNP Paribas Exane upgraded Sonova from a "strong sell" rating to a "strong-buy" rating in a research note on Tuesday, March 10th. Jefferies Financial Group downgraded Sonova from a "hold" rating to a "moderate sell" rating in a research note on Wednesday, March 18th. Finally, Zacks Research upgraded Sonova from a "strong sell" rating to a "hold" rating in a research note on Monday, February 9th. Two investment analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy".

Sonova Stock Down 1.8%

The stock has a 50-day simple moving average of $46.75 and a 200 day simple moving average of $50.55. The company has a quick ratio of 0.91, a current ratio of 1.24 and a debt-to-equity ratio of 0.51.

About Sonova

Sonova AG OTCMKTS: SONVY is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.